Concepts (261)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Polycystic Ovary Syndrome | 14 | 2024 | 376 | 6.210 |
Why?
|
| Hyperandrogenism | 3 | 2021 | 39 | 2.130 |
Why?
|
| Insulin Resistance | 10 | 2022 | 3963 | 1.080 |
Why?
|
| Synbiotics | 2 | 2021 | 12 | 0.950 |
Why?
|
| Oils, Volatile | 2 | 2021 | 14 | 0.900 |
Why?
|
| Plant Oils | 2 | 2021 | 198 | 0.820 |
Why?
|
| Levodopa | 1 | 2022 | 221 | 0.780 |
Why?
|
| Scaphoid Bone | 1 | 2022 | 85 | 0.770 |
Why?
|
| Osteochondritis Dissecans | 1 | 2022 | 118 | 0.740 |
Why?
|
| Osteonecrosis | 1 | 2022 | 229 | 0.720 |
Why?
|
| Glycyrrhiza | 1 | 2020 | 9 | 0.700 |
Why?
|
| Happiness | 1 | 2021 | 170 | 0.670 |
Why?
|
| Polyethyleneimine | 3 | 2024 | 68 | 0.650 |
Why?
|
| Iran | 11 | 2024 | 737 | 0.640 |
Why?
|
| Ovarian Diseases | 1 | 2020 | 137 | 0.640 |
Why?
|
| Fabaceae | 1 | 2018 | 103 | 0.610 |
Why?
|
| Probiotics | 1 | 2021 | 378 | 0.570 |
Why?
|
| Diet | 6 | 2023 | 8075 | 0.560 |
Why?
|
| Exercise Therapy | 2 | 2024 | 929 | 0.550 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2020 | 409 | 0.540 |
Why?
|
| Personal Satisfaction | 1 | 2021 | 644 | 0.540 |
Why?
|
| Sarcopenia | 1 | 2020 | 372 | 0.500 |
Why?
|
| Paclitaxel | 1 | 2022 | 1732 | 0.490 |
Why?
|
| Glucose Intolerance | 1 | 2019 | 575 | 0.480 |
Why?
|
| Counseling | 2 | 2019 | 1547 | 0.470 |
Why?
|
| Plasmids | 3 | 2024 | 2269 | 0.470 |
Why?
|
| Exercise | 6 | 2024 | 5890 | 0.440 |
Why?
|
| Lipids | 3 | 2021 | 3341 | 0.440 |
Why?
|
| Life Style | 3 | 2020 | 3917 | 0.420 |
Why?
|
| Molecular Weight | 3 | 2024 | 2186 | 0.420 |
Why?
|
| Pistacia | 2 | 2022 | 7 | 0.410 |
Why?
|
| Diabetic Neuropathies | 1 | 2016 | 405 | 0.400 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 2 | 2024 | 244 | 0.400 |
Why?
|
| Anthropometry | 3 | 2021 | 1349 | 0.400 |
Why?
|
| Cardiovascular Diseases | 7 | 2022 | 15500 | 0.380 |
Why?
|
| Obesity | 7 | 2022 | 12947 | 0.350 |
Why?
|
| Wound Healing | 2 | 2020 | 2805 | 0.350 |
Why?
|
| Health Status Disparities | 1 | 2020 | 1852 | 0.320 |
Why?
|
| Magnesium | 2 | 2022 | 804 | 0.300 |
Why?
|
| Cutaneous Fistula | 1 | 2008 | 79 | 0.300 |
Why?
|
| Cholesterol | 3 | 2022 | 2904 | 0.290 |
Why?
|
| Glycemic Index | 2 | 2021 | 396 | 0.280 |
Why?
|
| Blood Pressure | 7 | 2024 | 8481 | 0.280 |
Why?
|
| Pharyngeal Diseases | 1 | 2008 | 134 | 0.280 |
Why?
|
| Blood Glucose | 6 | 2022 | 6391 | 0.280 |
Why?
|
| Fistula | 1 | 2008 | 212 | 0.270 |
Why?
|
| Laryngectomy | 1 | 2008 | 243 | 0.260 |
Why?
|
| Quality of Life | 5 | 2024 | 13367 | 0.250 |
Why?
|
| Adult | 29 | 2024 | 221177 | 0.250 |
Why?
|
| Cholesterol, HDL | 3 | 2021 | 1814 | 0.250 |
Why?
|
| Female | 36 | 2024 | 392644 | 0.250 |
Why?
|
| Triglycerides | 3 | 2021 | 2461 | 0.240 |
Why?
|
| Interleukin-12 | 2 | 2024 | 584 | 0.240 |
Why?
|
| Dextrins | 1 | 2024 | 1 | 0.240 |
Why?
|
| Humans | 50 | 2024 | 761504 | 0.220 |
Why?
|
| Body Mass Index | 5 | 2021 | 12953 | 0.220 |
Why?
|
| Emulsions | 2 | 2021 | 152 | 0.210 |
Why?
|
| Insulin | 4 | 2022 | 6596 | 0.210 |
Why?
|
| Cross-Sectional Studies | 12 | 2024 | 26125 | 0.210 |
Why?
|
| Hypertension | 6 | 2024 | 8540 | 0.210 |
Why?
|
| Cholesterol, LDL | 3 | 2021 | 2382 | 0.200 |
Why?
|
| Pelvic Organ Prolapse | 1 | 2023 | 112 | 0.200 |
Why?
|
| Randomized Controlled Trials as Topic | 7 | 2022 | 10209 | 0.190 |
Why?
|
| Migraine Disorders | 2 | 2024 | 1701 | 0.180 |
Why?
|
| Valerates | 1 | 2020 | 20 | 0.180 |
Why?
|
| Hepatitis A virus | 1 | 2020 | 16 | 0.180 |
Why?
|
| Wrist Joint | 1 | 2022 | 267 | 0.180 |
Why?
|
| Dietary Supplements | 4 | 2021 | 3415 | 0.180 |
Why?
|
| Lavandula | 1 | 2020 | 4 | 0.180 |
Why?
|
| Cystitis, Interstitial | 1 | 2020 | 66 | 0.180 |
Why?
|
| Nanoparticles | 3 | 2024 | 1959 | 0.170 |
Why?
|
| Hepatitis A | 1 | 2020 | 128 | 0.170 |
Why?
|
| Prevalence | 5 | 2021 | 15732 | 0.170 |
Why?
|
| Metals, Heavy | 1 | 2021 | 148 | 0.170 |
Why?
|
| Plant Extracts | 2 | 2021 | 498 | 0.170 |
Why?
|
| Micronutrients | 1 | 2022 | 382 | 0.170 |
Why?
|
| Rats, Wistar | 2 | 2021 | 1848 | 0.170 |
Why?
|
| Acanthosis Nigricans | 1 | 2019 | 47 | 0.160 |
Why?
|
| Case-Control Studies | 4 | 2021 | 22176 | 0.160 |
Why?
|
| Lens Plant | 1 | 2018 | 5 | 0.160 |
Why?
|
| Hirsutism | 1 | 2019 | 68 | 0.160 |
Why?
|
| Ovarian Follicle | 1 | 2020 | 244 | 0.160 |
Why?
|
| Adolescent | 8 | 2022 | 88319 | 0.160 |
Why?
|
| Spouses | 1 | 2021 | 283 | 0.160 |
Why?
|
| Fatty Alcohols | 1 | 2018 | 22 | 0.150 |
Why?
|
| Zinc | 1 | 2022 | 690 | 0.150 |
Why?
|
| Catechols | 1 | 2018 | 62 | 0.150 |
Why?
|
| Carnitine | 1 | 2019 | 252 | 0.150 |
Why?
|
| Clergy | 1 | 2019 | 79 | 0.150 |
Why?
|
| Receptors, CCR5 | 1 | 2020 | 486 | 0.150 |
Why?
|
| Young Adult | 9 | 2023 | 59243 | 0.150 |
Why?
|
| Upper Extremity | 1 | 2022 | 657 | 0.150 |
Why?
|
| Middle Aged | 17 | 2023 | 220895 | 0.140 |
Why?
|
| Diet, Reducing | 1 | 2021 | 485 | 0.140 |
Why?
|
| Waist Circumference | 1 | 2021 | 935 | 0.140 |
Why?
|
| Muscle, Skeletal | 3 | 2021 | 4948 | 0.140 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2020 | 237 | 0.140 |
Why?
|
| Lipoproteins, LDL | 1 | 2020 | 642 | 0.140 |
Why?
|
| Surgery, Plastic | 1 | 2023 | 643 | 0.140 |
Why?
|
| Reproduction | 1 | 2021 | 645 | 0.130 |
Why?
|
| Coffee | 1 | 2021 | 593 | 0.130 |
Why?
|
| Sex Hormone-Binding Globulin | 1 | 2019 | 550 | 0.130 |
Why?
|
| Polypharmacy | 1 | 2019 | 306 | 0.130 |
Why?
|
| Ovary | 1 | 2020 | 959 | 0.130 |
Why?
|
| Glucose Tolerance Test | 1 | 2019 | 1178 | 0.130 |
Why?
|
| Health Status Indicators | 1 | 2020 | 970 | 0.120 |
Why?
|
| Virus Diseases | 1 | 2021 | 718 | 0.120 |
Why?
|
| Muscle Proteins | 1 | 2020 | 1154 | 0.120 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2019 | 12148 | 0.120 |
Why?
|
| Single-Blind Method | 1 | 2018 | 1572 | 0.120 |
Why?
|
| Fasting | 1 | 2020 | 1603 | 0.120 |
Why?
|
| Liposomes | 1 | 2018 | 784 | 0.110 |
Why?
|
| Acne Vulgaris | 1 | 2019 | 358 | 0.110 |
Why?
|
| RNA, Small Interfering | 1 | 2022 | 3429 | 0.110 |
Why?
|
| Canada | 1 | 2019 | 2122 | 0.110 |
Why?
|
| Diet, Mediterranean | 1 | 2020 | 740 | 0.110 |
Why?
|
| Respiratory Tract Infections | 1 | 2021 | 1010 | 0.110 |
Why?
|
| Risk Reduction Behavior | 1 | 2019 | 1112 | 0.110 |
Why?
|
| Osteoarthritis | 1 | 2021 | 1063 | 0.110 |
Why?
|
| Antioxidants | 1 | 2021 | 1668 | 0.110 |
Why?
|
| Aged | 10 | 2022 | 169289 | 0.100 |
Why?
|
| Automobile Driving | 1 | 2018 | 441 | 0.100 |
Why?
|
| Weight Gain | 1 | 2022 | 2348 | 0.100 |
Why?
|
| Polyethylene Glycols | 1 | 2018 | 1189 | 0.100 |
Why?
|
| Accidents, Traffic | 1 | 2018 | 816 | 0.100 |
Why?
|
| Diabetes, Gestational | 1 | 2022 | 1248 | 0.100 |
Why?
|
| Metabolic Diseases | 1 | 2018 | 683 | 0.100 |
Why?
|
| Environmental Pollutants | 1 | 2021 | 1277 | 0.100 |
Why?
|
| Cell Cycle | 1 | 2020 | 2932 | 0.100 |
Why?
|
| Disabled Persons | 1 | 2021 | 1225 | 0.100 |
Why?
|
| Analysis of Variance | 1 | 2020 | 6228 | 0.090 |
Why?
|
| Liver Neoplasms | 2 | 2020 | 4320 | 0.090 |
Why?
|
| Body Composition | 1 | 2020 | 2426 | 0.090 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2021 | 2273 | 0.090 |
Why?
|
| Male | 18 | 2024 | 360804 | 0.090 |
Why?
|
| Linear Models | 1 | 2020 | 5871 | 0.090 |
Why?
|
| Antihypertensive Agents | 1 | 2019 | 2024 | 0.080 |
Why?
|
| Cell Line, Tumor | 2 | 2024 | 16981 | 0.080 |
Why?
|
| Risk | 1 | 2021 | 9610 | 0.080 |
Why?
|
| Gene Transfer Techniques | 2 | 2024 | 1206 | 0.080 |
Why?
|
| Heart Rate | 1 | 2020 | 4195 | 0.080 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2020 | 1727 | 0.080 |
Why?
|
| Health Status | 1 | 2021 | 4077 | 0.080 |
Why?
|
| Electrocardiography | 1 | 2021 | 6377 | 0.080 |
Why?
|
| Multivariate Analysis | 1 | 2022 | 12059 | 0.080 |
Why?
|
| Pain | 1 | 2022 | 5073 | 0.070 |
Why?
|
| Bone Density | 1 | 2020 | 3551 | 0.070 |
Why?
|
| Risk Factors | 5 | 2020 | 74206 | 0.070 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2021 | 2243 | 0.070 |
Why?
|
| Prospective Studies | 5 | 2023 | 54425 | 0.070 |
Why?
|
| Transfection | 2 | 2024 | 5774 | 0.070 |
Why?
|
| Environmental Exposure | 1 | 2021 | 4486 | 0.070 |
Why?
|
| Cell Proliferation | 2 | 2020 | 10445 | 0.060 |
Why?
|
| Sleep | 1 | 2021 | 4768 | 0.060 |
Why?
|
| Dihydroxyphenylalanine | 1 | 2024 | 74 | 0.060 |
Why?
|
| Large Neutral Amino Acid-Transporter 1 | 1 | 2024 | 15 | 0.060 |
Why?
|
| Laryngeal Neoplasms | 1 | 2008 | 514 | 0.060 |
Why?
|
| Clinical Trials as Topic | 1 | 2020 | 8002 | 0.060 |
Why?
|
| Diabetes Mellitus | 1 | 2022 | 5840 | 0.060 |
Why?
|
| Apoptosis | 1 | 2020 | 9486 | 0.060 |
Why?
|
| Palliative Care | 1 | 2019 | 3598 | 0.060 |
Why?
|
| United States | 2 | 2021 | 72334 | 0.050 |
Why?
|
| Pelvic Floor | 1 | 2023 | 137 | 0.050 |
Why?
|
| Pancreatic Neoplasms | 1 | 2020 | 5368 | 0.050 |
Why?
|
| Erythrocyte Count | 1 | 2022 | 157 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2022 | 41487 | 0.050 |
Why?
|
| Mentha piperita | 1 | 2021 | 17 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 39106 | 0.050 |
Why?
|
| Panax | 1 | 2021 | 28 | 0.050 |
Why?
|
| Models, Statistical | 1 | 2016 | 5079 | 0.050 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2014 | 2298 | 0.050 |
Why?
|
| Manometry | 1 | 2023 | 454 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 2 | 2020 | 6132 | 0.050 |
Why?
|
| Radiotherapy | 1 | 2008 | 1499 | 0.050 |
Why?
|
| Logistic Models | 1 | 2016 | 13255 | 0.050 |
Why?
|
| Hepatitis A Antibodies | 1 | 2020 | 19 | 0.050 |
Why?
|
| Risk Assessment | 2 | 2020 | 23995 | 0.050 |
Why?
|
| Administration, Intravesical | 1 | 2020 | 92 | 0.050 |
Why?
|
| Quercetin | 1 | 2021 | 97 | 0.050 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 18252 | 0.040 |
Why?
|
| Australia | 1 | 2024 | 1250 | 0.040 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2020 | 103 | 0.040 |
Why?
|
| Magnesium Deficiency | 1 | 2020 | 48 | 0.040 |
Why?
|
| Hematocrit | 1 | 2022 | 623 | 0.040 |
Why?
|
| beta-Glucans | 1 | 2021 | 123 | 0.040 |
Why?
|
| Rats, Nude | 1 | 2020 | 105 | 0.040 |
Why?
|
| Rats | 3 | 2021 | 23742 | 0.040 |
Why?
|
| Lactobacillus | 1 | 2021 | 212 | 0.040 |
Why?
|
| Animals | 6 | 2024 | 168459 | 0.040 |
Why?
|
| Particle Size | 1 | 2024 | 1648 | 0.040 |
Why?
|
| Nuts | 1 | 2021 | 264 | 0.040 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2021 | 144 | 0.040 |
Why?
|
| Artificial Intelligence | 2 | 2024 | 2578 | 0.040 |
Why?
|
| Genes, Regulator | 1 | 2020 | 373 | 0.040 |
Why?
|
| Surgical Flaps | 1 | 2008 | 1671 | 0.040 |
Why?
|
| Myostatin | 1 | 2020 | 129 | 0.040 |
Why?
|
| Seroepidemiologic Studies | 1 | 2020 | 397 | 0.040 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2022 | 731 | 0.040 |
Why?
|
| Constipation | 1 | 2023 | 563 | 0.040 |
Why?
|
| Hindlimb | 1 | 2021 | 513 | 0.040 |
Why?
|
| Resistance Training | 1 | 2020 | 193 | 0.040 |
Why?
|
| Area Under Curve | 1 | 2022 | 1638 | 0.040 |
Why?
|
| Pregnancy Trimester, First | 1 | 2022 | 907 | 0.040 |
Why?
|
| Child | 2 | 2022 | 80153 | 0.040 |
Why?
|
| Sex Factors | 2 | 2021 | 10552 | 0.030 |
Why?
|
| Checklist | 1 | 2024 | 827 | 0.030 |
Why?
|
| Physical Conditioning, Animal | 1 | 2020 | 365 | 0.030 |
Why?
|
| Fibronectins | 1 | 2020 | 723 | 0.030 |
Why?
|
| Nutritive Value | 1 | 2019 | 350 | 0.030 |
Why?
|
| Headache | 1 | 2024 | 1256 | 0.030 |
Why?
|
| Hemoglobins | 1 | 2022 | 1525 | 0.030 |
Why?
|
| Algorithms | 1 | 2016 | 14031 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2018 | 13639 | 0.030 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2021 | 1722 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2021 | 4575 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2023 | 2135 | 0.030 |
Why?
|
| Delayed-Action Preparations | 1 | 2018 | 962 | 0.030 |
Why?
|
| Age Factors | 2 | 2021 | 18395 | 0.030 |
Why?
|
| Cell Survival | 1 | 2024 | 5791 | 0.030 |
Why?
|
| Drug Carriers | 1 | 2018 | 706 | 0.030 |
Why?
|
| Behavior, Animal | 1 | 2021 | 1878 | 0.030 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2020 | 1934 | 0.030 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2008 | 4026 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2021 | 6075 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2021 | 15266 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2020 | 3602 | 0.020 |
Why?
|
| Cost of Illness | 1 | 2021 | 1936 | 0.020 |
Why?
|
| Vitamin D Deficiency | 1 | 2021 | 1388 | 0.020 |
Why?
|
| DNA | 1 | 2024 | 7212 | 0.020 |
Why?
|
| Health Surveys | 1 | 2020 | 4061 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2018 | 21012 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2023 | 64680 | 0.020 |
Why?
|
| Aged, 80 and over | 3 | 2020 | 58976 | 0.020 |
Why?
|
| Neoplasms | 1 | 2019 | 22170 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2021 | 3113 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2020 | 8181 | 0.020 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2024 | 4016 | 0.020 |
Why?
|
| Overweight | 1 | 2020 | 2417 | 0.020 |
Why?
|
| Stromal Cells | 1 | 2014 | 1330 | 0.020 |
Why?
|
| Vaccination | 1 | 2020 | 3384 | 0.020 |
Why?
|
| Cell Movement | 1 | 2020 | 5203 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2019 | 3688 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 2019 | 3188 | 0.020 |
Why?
|
| Vitamin D | 1 | 2021 | 3303 | 0.020 |
Why?
|
| Comorbidity | 1 | 2021 | 10508 | 0.020 |
Why?
|
| Drug Delivery Systems | 1 | 2018 | 2226 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2022 | 14666 | 0.020 |
Why?
|
| Prognosis | 2 | 2019 | 29625 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2019 | 3600 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2024 | 20098 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2022 | 14605 | 0.020 |
Why?
|
| Liver | 1 | 2021 | 7529 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2023 | 80636 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 7390 | 0.010 |
Why?
|
| Tumor Microenvironment | 1 | 2014 | 3877 | 0.010 |
Why?
|
| Epigenesis, Genetic | 1 | 2014 | 3802 | 0.010 |
Why?
|
| Time Factors | 1 | 2021 | 39967 | 0.010 |
Why?
|
| Pregnancy | 1 | 2022 | 29874 | 0.010 |
Why?
|
| MicroRNAs | 1 | 2014 | 3816 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2014 | 8547 | 0.010 |
Why?
|
| Mice | 1 | 2024 | 81525 | 0.010 |
Why?
|
Concepts
(261)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(9)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_